Inactief instrument

Andere talen Crescita Therapeutics Inc. Other OTC

Aandelen

CRRTF

CA2258471028

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Crescita Therapeutics Q1 Loss Widens, Revenue Rises	08/05
Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million	08/05
Crescita Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Crescita Reports First Quarter 2024 Results	08/05
Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share	13/03
Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.	13/03
Crescita Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Crescita Therapeutics Brief: Q4 EPS Basic and Diluted Loss $0.01	13/03
Crescita Reports Q4 and Fiscal 2023 Results	13/03
Crescita Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
North American Morning Briefing : Stock Futures -2-	13/03
Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.	08/11
Crescita Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Crescita Reports Third Quarter 2023 Results	08/11
Crescita Therapeutics Obtains TSX Approval for Normal Course Issuer Bid	29-08-23
Crescita Therapeutics Brief: Announced Approval of Normal Course Issuer Bid	29-08-23
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid	29-08-23
Crescita Therapeutics Inc. announces an Equity Buyback for 1,821,616 shares, representing 8.94% of its issued share capital.	29-08-23
Crescita Therapeutics Inc. authorizes a Buyback Plan.	29-08-23
- Crescita Therapeutics Brief: Q2 Revenue $5.162 Million; Ending cash was $10,226, down $49 for the quarter	09-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Crescita Therapeutics Inc. Other OTC

Aandelen

CRRTF

CA2258471028

Andere talen

Filters